MGNX Stock Cash Flow Statements

MacroGenics Quarterly Cash Flow Statements Chart

Quarterly

Annual

Stock-Based Compensation

Operating Cash Flow

Investing Cash Flow

Financing Cash Flow

Free Cash Flow

Capital Expenditure

MacroGenics Quarterly Cash Flow Statements Table

Quarterly

Annual

Unit: USD	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30	2021-03-31	2020-12-31	2020-09-30	2020-06-30	2020-03-31	2019-12-31	2019-09-30	2019-06-30	2019-03-31	2018-12-31	2018-09-30	2018-06-30	2018-03-31	2017-12-31	2017-09-30	2017-06-30	2017-03-31	2016-12-31	2016-09-30	2016-06-30	2016-03-31	2015-12-31	2015-09-30	2015-06-30	2015-03-31	2014-12-31	2014-09-30	2014-06-30	2014-03-31	2013-12-31

cash flows from operating activities
net income	-36,251,000	-41,036,000	-15,421,000	56,309,000	-55,664,000	-52,190,000	-46,072,000	17,554,000	57,469,000	-38,009,000	12,802,000	-24,813,000	-41,304,000	-66,443,000	-58,022,000	-52,886,000	-39,935,000	-51,272,000	-2,087,000	-36,043,000	-46,885,000	-44,724,000	-30,396,000	-44,631,000	-31,767,000	-45,017,000	-44,644,000	-34,029,000	-43,244,000	-49,536,000	105,727,000	-47,043,000	-40,655,000	-37,655,000	-34,783,000	-33,846,000	40,464,000	-30,363,000	-28,451,000	-15,442,000	-21,376,000	45,129,000	-19,018,000	-3,928,000	-12,258,665	-3,108,335	-3,204,984
adjustments to reconcile net income loss to net cash from operating activities:
depreciation and amortization expense	1,907,000	1,771,000		1,835,000	1,811,000	1,841,000		1,950,000	2,812,000	2,983,000		2,844,000	2,877,000	2,913,000		2,796,000	2,781,000	2,729,000				2,809,000		2,636,000	2,580,000	2,903,000		2,728,000	1,202,000	1,338,000	1,342,000	1,905,000	2,003,000	1,978,000	1,974,000	2,077,000	1,786,000	1,771,000
amortization of premiums and discounts on marketable securities	-311,000	-182,000	-185,000	-371,000	-939,000	-1,315,000	-1,728,000	-1,872,000	-1,032,000	-372,000	-337,000	112,000	294,000	334,000	340,000	459,000	441,000	367,000	127,000	14,000
stock-based compensation	3,690,000	4,386,000		5,970,000	6,651,000	5,553,000		4,790,000	4,391,000	4,833,000		5,123,000	5,300,000	5,274,000		6,358,000	6,070,000	5,286,000		5,832,000	5,096,000	4,491,000		5,398,000	4,884,000	3,799,000		4,573,000	4,163,000	3,432,000
non-cash interest expense							0	0	774,000	656,000
non-cash lease expense	400,000	399,000	-2,498,000	607,000	611,000	617,000	786,000	869,000	893,000	941,000
other non-cash items			0	-19,000			0	187,000			0	1,805,000			433,000
changes in operating assets and liabilities:
accounts receivable	-1,990,000	-6,233,000	4,442,000	-2,560,000	1,028,000	3,148,000	14,944,000	-18,901,000	29,750,000	20,062,000	-42,384,000	4,547,000	-3,479,000	-4,520,000	3,374,000	31,488,000	-38,100,000	15,934,000	-4,304,000	428,000	-7,399,000	938,000	-3,241,000	-3,891,000	503,000	23,468,000	-8,613,000	-3,134,000	-10,555,000	6,361,000	-11,448,000	-203,000	102,000	671,000	244,000	75,367,000	-75,864,000	-1,287,000	1,520,000	1,590,000	-2,615,000	1,216,000	2,380,000	-2,670,000	-899,279	258,279	277,263
inventory	151,000	-9,426,000	-165,000	-2,129,000	133,000	-27,000	-155,000	377,000	-34,000	42,000	-364,000	57,000	572,000	-210,000	-842,000	894,000	-304,000	-6,172,000
prepaid expenses and other current assets	1,327,000	3,535,000	-1,675,000	-565,000	598,000	75,000	-1,436,000	-2,035,000	3,243,000	443,000	-889,000	3,287,000	2,154,000	6,457,000	-3,108,000	-106,000	265,000	-1,239,000		-2,439,000
other non current assets	93,000	66,000	-370,000	0	-1,000	201,000	0	0			-13,172,000	846,000	821,000	801,000
accounts payable	-1,640,000	1,252,000	-1,700,000	1,413,000	-5,422,000	4,179,000	2,888,000	-503,000	44,000	-1,148,000	37,000	1,999,000	-976,000	-11,920,000	9,056,000	-3,599,000	-161,000	1,829,000	3,586,000	1,613,000	810,000	-2,286,000	1,700,000	1,685,000									197,000	-2,223,000	2,365,000	222,000	33,000	-388,000	-1,035,000	688,000	409,000	-225,000	-2,719,000	411,000	-1,156,016	1,964,016	1,370,806
accrued expenses and other current liabilities	-6,488,000	-1,163,000	4,355,000	198,000	6,341,000	-5,891,000	-1,435,000	-2,095,000	-616,000	-677,000	-4,454,000	1,513,000	-1,154,000	-543,000	-8,351,000	2,379,000	4,510,000	855,000
lease liabilities	-219,000	5,000	3,362,000	42,000	45,000	41,000	-138,000	-210,000	-229,000	-284,000	12,811,000	-1,183,000	-1,145,000	-1,119,000	-1,079,000	-1,028,000	-990,000	-683,000	789,000	-579,000	-665,000	-869,000	-966,000	3,616,000	-855,000	1,086,000
deferred revenue	-7,941,000	-264,000	-7,330,000	-511,000	302,000	-1,875,000	-1,950,000	14,635,000	954,000	-2,213,000	57,298,000	-5,559,000	-14,198,000	11,280,000	-5,243,000	-4,152,000	19,260,000	-601,000	-3,656,000	-1,049,000	-1,519,000	-2,248,000	-13,755,000	3,747,000	-5,431,000	-5,430,000	19,212,000	-2,436,000	-1,936,000	-1,435,000	9,199,000	-800,000	-801,000	-1,065,000	729,000	-1,741,000	-1,286,000	-1,893,000	-555,000	-3,856,000	-3,863,000	-3,949,000	-3,949,000	-9,927,000	7,769,523	9,423,477	-2,707,650
other non current liabilities															0			258,000
net cash from operating activities	-46,985,000	-46,890,000	-38,407,000	60,162,000	-44,485,000	-45,643,000	-28,037,000	-35,246,000	-2,089,000	-12,833,000	29,320,000	-9,422,000	-49,161,000	-57,696,000	-54,309,000	-14,795,000	-45,690,000	-29,036,000	-5,533,000	-25,677,000	-36,546,000	-44,142,000	-38,044,000	-17,388,000	-48,838,000	-30,000,000	-27,228,000	-36,980,000	-57,731,000	-31,295,000	111,845,000	-31,354,000	-30,755,000	-35,331,000	-28,329,000	49,786,000	-33,226,000	-31,910,000	-24,155,000	-7,634,000	-25,465,000	43,593,000	-20,164,000	-14,331,000	-4,150,230	5,886,230	-1,183,683
capex	-715,000	-529,000	-620,000	-592,000	-1,035,000	-1,459,000	-620,000	-499,000	-286,000	-359,000	-393,000	-804,000	-1,011,000	-1,415,000	-1,375,000	-2,133,000	-2,067,000	-626,000	0	-499,000	-594,000	-1,253,000	0	-780,000	-587,000	-1,675,000	0	-4,216,000	-5,504,000	-14,519,000	0	-9,850,000	-7,303,000	-1,492,000	-1,062,000	-1,980,000	-5,508,000	-2,831,000	-2,780,000	-2,608,000	-2,812,000	-997,000	-1,658,000	-672,000	-794,725	-447,275	-924,076
free cash flows	-47,700,000	-47,419,000	-39,027,000	59,570,000	-45,520,000	-47,102,000	-28,657,000	-35,745,000	-2,375,000	-13,192,000	28,927,000	-10,226,000	-50,172,000	-59,111,000	-55,684,000	-16,928,000	-47,757,000	-29,662,000	-5,533,000	-26,176,000	-37,140,000	-45,395,000	-38,044,000	-18,168,000	-49,425,000	-31,675,000	-27,228,000	-41,196,000	-63,235,000	-45,814,000	111,845,000	-41,204,000	-38,058,000	-36,823,000	-29,391,000	47,806,000	-38,734,000	-34,741,000	-26,935,000	-10,242,000	-28,277,000	42,596,000	-21,822,000	-15,003,000	-4,944,955	5,438,955	-2,107,759
cash flows from investing activities
purchases of marketable securities	-45,513,000	-7,915,000	-13,788,000	-4,889,000	-8,008,000	-50,497,000	-22,467,000	-69,176,000	-130,744,000	-17,296,000	-45,145,000	0	-21,380,000	-54,077,000	-66,428,000	-47,234,000	-23,665,000	-93,881,000	-72,515,000	-79,031,000	-11,013,000	-61,186,000	-50,221,000	-71,873,000	-60,708,000	-81,597,000	-12,711,000	-33,548,000	-62,039,000	-24,452,000	-45,998,000	-32,187,000	0	-56,937,000	-78,065,000	-67,305,000	-119,276,000	-83,116,000
proceeds from sale and maturities of marketable securities	8,590,000	18,346,000		41,000,000	56,400,000	76,750,000		36,140,000	17,500,000	45,750,000		72,750,000	45,430,000	37,010,000		46,750,000	39,550,000	60,250,000		36,249,000	52,614,000	73,003,000		66,281,000	51,175,000	12,780,000		37,758,000	59,732,000	58,358,000		46,501,000	80,433,000	50,072,000		66,122,000	68,198,000	73,413,000
purchases of property, equipment and software	-715,000	-529,000	-620,000	-592,000	-1,035,000	-1,459,000	-620,000	-499,000	-286,000	-359,000	-393,000	-804,000	-1,011,000	-1,415,000	-1,375,000	-2,133,000	-2,067,000	-626,000
proceeds from sales of equipment			0	80,000			0	10,000
net cash from investing activities	-37,638,000	9,902,000	41,467,000	35,599,000	47,437,000	24,794,000	38,822,000	-33,525,000	-113,476,000	28,095,000	-5,788,000	71,946,000	23,039,000	-18,482,000	-13,553,000	-2,617,000	13,818,000	-34,257,000	-16,075,000	-43,281,000	41,007,000	10,564,000	7,626,000	-6,372,000	-10,120,000	-70,492,000	45,074,000	-6,000	-7,811,000	19,387,000	8,639,000	4,464,000	73,130,000	-8,357,000	2,034,000	-3,163,000	-56,586,000	-12,534,000	-145,690,000	-2,608,000	-2,812,000	-997,000	-1,658,000	-672,000	-794,725	-447,275	-924,076
cash flows from financing activities
proceeds from stock option exercises and espp purchases			159,000	6,000	631,000	2,639,000	274,000	52,000	222,000	5,000	260,000	14,000			-763,000	812,000	2,452,000	2,458,000	1,141,000	2,092,000	2,503,000	162,000	297,000	37,000			735,000	132,000	496,000	629,000	449,000	28,000
taxes paid related to net share settlement of equity awards	0	-282,000	-4,000	-74,000	-6,000	-2,391,000	0	-141,000	-7,000	-158,000						-1,457,000
net proceeds from sale of future royalties							0	50,000,000	0	99,655,000
net cash from financing activities	69,739,000	-282,000	155,000	-68,000	625,000	248,000	273,000	49,911,000	59,000	100,118,000	1,359,000	0	263,000	37,000	800,000	18,973,000	2,346,000	100,658,000	1,102,000	74,063,000	99,015,000	162,000	297,000	37,000	633,000	119,005,000	475,000	132,000	103,755,000	629,000	359,000	1,147,000	33,734,000	108,000	492,000	1,011,000	127,000	224,000	250,000	140,982,000	170,000	62,947,000	222,000	180,000	237,548	76,801,452	85,019,970
net change in cash and cash equivalents	-14,884,000	-37,270,000	3,215,000	95,693,000	3,577,000	-20,601,000	11,058,000	-18,860,000	-115,506,000	115,380,000	24,891,000	62,524,000	-25,859,000	-76,141,000	-67,062,000	1,561,000	-29,526,000	37,365,000	-20,506,000	5,105,000	103,476,000	-33,416,000	-30,121,000	-23,723,000	-58,325,000	18,513,000	18,321,000	-36,854,000	38,213,000	-11,279,000	120,843,000	-25,743,000	76,109,000	-43,580,000	-25,803,000	47,634,000	-89,685,000	-44,220,000	-169,595,000	130,740,000	-28,107,000	105,543,000	-21,600,000	-14,823,000	-4,707,407	82,240,407	82,912,211
cash and cash equivalents at beginning of period	0	182,840,000	0	0	0	100,956,000	0	0	0	108,884,000	0	0	0	123,469,000	0	0	0	181,131,000	0	0	0	126,472,000	0	0	0	220,128,000	0	0	0	211,727,000	0	0	0	84,098,000	0	0	0	196,172,000	0	0	0	157,591,000	0	0	-409	116,481,409	0
cash and cash equivalents at end of period	-14,884,000	145,570,000	3,215,000	95,693,000	3,577,000	80,355,000	11,058,000	-18,860,000	-115,506,000	224,264,000	24,891,000	62,524,000	-25,859,000	47,328,000	-67,062,000	1,561,000	-29,526,000	218,496,000	-20,506,000	5,105,000	103,476,000	93,056,000	-30,121,000	-23,723,000	-58,325,000	238,641,000	18,321,000	-36,854,000	38,213,000	200,448,000	120,843,000	-25,743,000	76,109,000	40,518,000	-25,803,000	47,634,000	-89,685,000	151,952,000	-169,595,000	130,740,000	-28,107,000	263,134,000	-21,600,000	-14,823,000	-4,707,816	198,721,816	82,912,211
supplemental cash flow disclosures
cash paid for income taxes
non-cash operating and investing activities
property and equipment included in accounts payable or accruals
supplemental cash flow information
property, equipment and software included in accounts payable or accruals		353,000			-206,000	242,000		-11,000	0	177,000		0	144,000	151,000		-49,000	-368,000	486,000
operating activities
adjustments to reconcile net income to net cash from operating activities:
depreciation and amortization
share-based compensation																																	3,602,000	3,461,000	3,039,000	3,002,000	3,123,000	3,001,000	2,216,000	2,098,000	1,902,000	1,631,000	995,000	856,000	781,396	611,604	468,601
gain on royalty monetization arrangement							0	-50,000,000
gain on sale of margenza
(gain) loss on disposal of assets			0
proceeds from sales and maturities of marketable securities
proceeds from sale of margenza
proceeds from issuance of common stock, net of offering costs							0	0	0	616,000					0	19,618,000	0	98,200,000	-38,000	73,982,000			0	0	0	118,657,000	0	0			-50,000	1,119,000							0	140,775,000	0	62,692,000	-17,000	-306,000	237,548	76,801,452
principal payments on royalty monetization arrangement							-1,000	0
loss on disposal of assets							0	8,000
non-cash royalty revenue										-90,000
proceeds from stock option exercises														37,000												348,000								108,000	531,000	1,011,000	127,000	224,000	279,000	207,000	170,000	255,000	258,000
right-of-use assets modified in exchange for operating lease obligation
other assets																742,000	731,000	3,673,000	-1,034,000	620,000	300,000	695,000	1,043,000	18,470,000	-19,012,000	-2,079,000	4,713,000	-3,782,000	-5,551,000	40,000	94,000	103,000	146,000	-81,000	875,000	-173,000	-128,000	-298,000					-1,331,000	381,000	1,165,347	-1,394,347
prepaid expenses																						-1,345,000	734,000	-2,403,000	-1,307,000	-1,902,000	-2,091,000	-1,142,000	155,000	-177,000	110,000	747,000	1,010,000	-1,535,000	-2,172,000	2,471,000	-2,079,000	103,000	178,000	1,082,000	551,000	594,000	-1,758,000	-353,000	-163,200	-964,800	131,744
deferred rent																											-233,000	-222,000	-204,000	-312,000	-367,000	7,137,000	-329,000	-326,000	-288,000	-283,000	-283,000	-280,000	48,000	5,052,000	-426,000	-24,000	-38,000	-45,000	-45,310	-105,690	15,539
purchase of treasury stock
non-cash operating and investing activities:
fair value of warrants received
depreciation expense																				2,962,000																			1,192,000	489,000	636,000	546,000	505,000	482,000	436,783	398,217	358,725
accrued expenses																				2,162,000	5,455,000	-2,118,000	-1,379,000	-2,015,000	1,634,000	-4,297,000	-5,954,000	1,245,000	6,738,000	1,477,000	3,331,000	3,316,000	4,362,000	1,823,000	764,000	3,029,000	2,654,000	-1,788,000	2,355,000	815,000	1,304,000	-929,000	3,899,000	721,000	574,399	-848,399	2,643,741
other liabilities																				802,000	928,000	515,000
purchases of property and equipment																				-499,000	-594,000	-1,253,000		-780,000	-587,000	-1,675,000		-4,216,000	-5,504,000	-14,519,000		-9,850,000	-7,303,000	-1,492,000	-1,062,000	-1,980,000	-5,508,000	-2,831,000	-2,780,000	-2,608,000	-2,812,000	-997,000	-1,658,000	-672,000	-794,725	-447,275	-924,076
right-of-use assets modified in exchange for operating lease obligations																								4,420,000	0	1,988,000
lease exit liability																												0	0	-298,000	-417,000	-405,000	-392,000	-379,000	-349,000	-339,000	-1,646,000	-488,000	-460,000	-450,000	-1,987,000	-396,000	-372,000	-364,000	-355,208	-347,792	-162,468
accounts payable and other liabilities																										-2,531,000		-781,000	-8,499,000	7,815,000
fair value of warrants received, including change in value
restricted cash																																							0				0
fair value adjustment of warrant liability																																															0
noncash financing activities:
conversion of preferred stock
fair value adjustment of warrant liabilities
proceeds from issuance of preferred stock
proceeds from issuance of common stock

We provide you with 20 years of cash flow statements for MacroGenics stock, allowing you to gain comprehensive visibility into the fundamentals of the company. Our detailed breakdowns include key financial metrics such as operating cash flows, cash levels, capital expenditures, profits, stock-based compensations and profit margins. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of MacroGenics stock. Explore the full financial landscape of MacroGenics stock with our expertly curated income statements.

The information provided in this report about MacroGenics stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.